Subscribe

Transfar Zhilian Co., Ltd. (002010.SZ)

CNY4.63 +0.10 (+2.21%)
CN SHZ Basic Materials Chemicals - Specialty
Address Chuanhua Building 311215
Hangzhou, CN
CEO Jiahai Zhou
Website transfarzl.com
IPO 2004-06-29
ISIN CNE000001JS7

Explore sections of this company profile

Description

Headquartered in Hangzhou, China, Transfar Zhilian Co., Ltd. commenced operations in 2001 and functions as a subsidiary of Transfar Group Co., Ltd. The company's operations are divided into two primary business divisions: Chemicals and Logistics. Within its Chemicals division, the firm manufactures and distributes a diverse array of chemical products across northern, eastern, and southern regions of China. These offerings encompass dyeing additives, various dyes, specialized oils for leather and chemical fibers, chemicals utilized in paint and construction, butadiene rubbers, and essential commodities like fuels and tires. Beyond chemicals, its Logistics segment delivers comprehensive services such as transportation subcontracting, warehousing solutions, and various value-added logistical support. Additionally, the company is involved in hotel leasing. Its activities also extend to participating in the joint development of critical infrastructure like highways and ports. Known previously as Zhejiang Transfar Co.,Ltd., the organization officially adopted its current name, Transfar Zhilian Co., Ltd., in November 2016.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
CNY4.63 +0.10 (+2.21%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
23M
Beta
0.69
Float Shares
2.74B
Free Float %
99.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.54% -3.95% -2.95% -14.63% -12.50% -3.61% +4.87% +0.18% -8.79% -67.06% +84.21%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
4.63
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.58
Distress
Piotroski F-Score
6 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    -6.5% Q1'26: -34.4% (vs Q1'25)
  • ✓
    EPS growth Chemicals - Specialty: +13.2%
    +320.0% ★ Q1'26: +34.8% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    -1.0% Q1'26: -25.1% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +3.4% Q1'26: +7.0% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +2.0% Q1'26: +3.0% (vs Q1'25)
  • ✓
    Share dilution Chemicals - Specialty: +0.1%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    12.33× Q1'26: 13.23× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.75) × ERP
WACC = 51% × Ke + 49% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 4.63
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
5.34B
est: 5.64B (-5.3%)
8.17B
est: 8.21B (-0.5%)
19.28B
est: 14.34B (+34.5%)
20.26B
est: 24.80B (-18.3%)
20.28B
est: 22.40B (-9.4%)
21.64B
est: 22.96B (-5.7%)
35.51B
est: 36.82B (-3.5%)
37.00B
est: 44.15B (-16.2%)
33.64B
est: 51.24B (-34.4%)
26.72B
est: 34.88B (-23.4%)
24.98B
est: 25.55B (-2.2%)
24.32B
24.32B – 24.32B
-4.8% YoY
24.69B
24.69B – 24.69B
+1.6% YoY
25.71B
25.71B – 25.71B
+4.1% YoY
EBITDA
989.50M
est: 325.41M (+204.1%)
1.25B
est: 473.77M (+164.8%)
1.23B
est: 827.60M (+48.2%)
1.97B
est: 1.43B (+37.4%)
2.70B
est: 1.29B (+108.7%)
2.60B
est: 1.33B (+96.4%)
3.73B
est: 2.13B (+75.6%)
1.95B
est: 2.55B (-23.3%)
2.00B
est: 2.96B (-32.5%)
1.37B
est: 2.20B (-37.7%)
1.17B
est: 1.61B (-27.3%)
1.53B
1.53B – 1.53B
-4.8% YoY
1.56B
1.56B – 1.56B
+1.6% YoY
1.62B
1.62B – 1.62B
+4.1% YoY
EBIT
879.00M
est: 265.42M (+231.2%)
1.12B
est: 386.42M (+190.6%)
1.02B
est: 675.01M (+51.0%)
1.71B
est: 1.17B (+46.9%)
2.43B
est: 1.05B (+130.8%)
2.31B
est: 1.08B (+113.8%)
3.47B
est: 1.73B (+99.9%)
1.70B
est: 2.08B (-18.4%)
1.55B
est: 2.41B (-35.7%)
1.05B
est: 1.84B (-42.8%)
855.70M
est: 1.34B (-36.3%)
1.28B
1.28B – 1.28B
-4.8% YoY
1.30B
1.30B – 1.30B
+1.6% YoY
1.35B
1.35B – 1.35B
+4.1% YoY
Net Income
550.63M
est: 353.36M (+55.8%)
680.73M
est: 545.96M (+24.7%)
469.41M
est: 576.30M (-18.5%)
818.99M
est: 712.79M (+14.9%)
1.60B
est: 1.40B (+14.8%)
1.52B
est: 1.94B (-21.6%)
2.25B
est: 1.64B (+37.3%)
745.16M
est: 1.91B (-61.0%)
590.94M
est: 1.88B (-68.6%)
151.66M
est: 663.37M (-77.1%)
589.65M
est: 746.29M (-21.0%)
884.49M
884.49M – 884.49M
+18.5% YoY
1.22B
1.22B – 1.22B
+37.5% YoY
1.44B
1.44B – 1.44B
+18.2% YoY
SGA
1.00B
est: 300.60M (+233.6%)
1.49B
est: 437.65M (+240.6%)
1.66B
est: 764.51M (+116.5%)
1.74B
est: 1.32B (+31.3%)
1.66B
est: 1.19B (+39.1%)
1.39B
est: 1.22B (+13.9%)
1.68B
est: 1.96B (-14.4%)
1.60B
est: 2.35B (-32.1%)
1.64B
est: 2.73B (-40.1%)
1.68B
est: 1.98B (-15.0%)
2.04B
est: 1.45B (+40.5%)
1.38B
1.38B – 1.38B
-4.8% YoY
1.40B
1.40B – 1.40B
+1.6% YoY
1.46B
1.46B – 1.46B
+4.1% YoY
EPS
0.20
est: 0.12 (+71.7%)
0.21
est: 0.18 (+16.7%)
0.14
est: 0.19 (-26.3%)
0.25
est: 0.24 (+6.4%)
0.49
est: 0.46 (+6.5%)
0.47
est: 0.64 (-26.6%)
0.72
est: 0.54 (+33.3%)
0.26
est: 0.63 (-58.7%)
0.21
est: 0.62 (-66.1%)
0.05
est: 0.24 (-77.1%)
0.21
est: 0.27 (-22.2%)
0.32
0.32 – 0.32
+18.5% YoY
0.44
0.44 – 0.44
+37.5% YoY
0.52
0.52 – 0.52
+18.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 B- 3/5 1/5 3/5 4/5 1/5 2/5 4/5
2026-05-11 B- 3/5 1/5 3/5 4/5 1/5 2/5 4/5
2026-05-08 B- 3/5 1/5 3/5 4/5 1/5 2/5 4/5
2026-05-07 B- 3/5 1/5 3/5 4/5 1/5 2/5 4/5
2026-05-06 B- 3/5 1/5 3/5 4/5 1/5 2/5 4/5
2026-04-30 B- 3/5 1/5 3/5 4/5 1/5 2/5 4/5
2026-04-29 B 3/5 1/5 3/5 5/5 1/5 2/5 4/5
2026-04-28 B 3/5 1/5 3/5 5/5 1/5 2/5 4/5
2026-04-27 B 3/5 1/5 3/5 5/5 1/5 2/5 4/5
2026-04-24 B 3/5 1/5 3/5 5/5 1/5 2/5 4/5
2026-04-23 B 3/5 1/5 3/5 5/5 1/5 2/5 4/5
2026-04-22 B 3/5 1/5 3/5 5/5 1/5 2/5 4/5
2026-04-21 B- 3/5 1/5 3/5 5/5 1/5 1/5 4/5
2026-04-20 B- 3/5 1/5 3/5 5/5 1/5 1/5 4/5
2026-04-17 B- 3/5 1/5 3/5 5/5 1/5 1/5 4/5
2026-04-16 B- 3/5 1/5 3/5 5/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-919.54M
OE per share TTM
-0.33
Owner's Yield
-5.97%
Maintenance CapEx ratio
156.36%
Maint CapEx / Avg PPE
10.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 27 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P China ETF GXC 0.02% 107.4K 0.59%
2 Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L 0.00% 105.3K 0.17%
3 Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L 0.00% 105.3K 0.17%
4 Vanguard FTSE All-World UCITS ETF (USD) Distributing VWRD.L 0.00% 893.9K 0.19%
5 Vanguard FTSE All-World UCITS ETF (USD) Accumulating VWRA.L 0.00% 893.9K 0.19%
6 Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO 0.00% 36.6K 0.26%
7 Vanguard FTSE Emerging Markets Shares ETF VGE.AX 0.00% 16.2K 0.48%
8 Vanguard FTSE Emerging Markets ETF VWO 0.00% 1.81M 0.06%
9 State Street SPDR Portfolio Emerging Markets ETF SPEM 0.00% 179.7K 0.07%
10 Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX 0.00% 5.8K 0.40%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
182.1K
Shares Outstanding
2.76B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jiahai Zhou Chairman & GM — male
Jiangying Zhu Deputy GM, Secretary of the Board of Directors & Director — female
Sheng Peng Wang Deputy General Manager — male
Shengxue Zhou Deputy GM & Director — male
Yan Xu Vice President — male
Yaping Qu Vice President & Director — male
Yongxin Xu Financial Director — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty